1.Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A: Global cancer statistics, 2012. CA Cancer J Clin 2015, 65(2):87–108.
2.zur Hausen H: Papillomaviruses and cancer: from basic studies to clinical application. Nat Rev Cancer 2002, 2(5):342–350.
3.Bloem P, Ogbuanu I: Vaccination to prevent human papillomavirus infections: From promise to practice. PLoS Med 2017, 14(6):e1002325.
4.Arbyn M, Raifu AO, Weiderpass E, Bray F, Anttila A: Trends of cervical cancer mortality in the member states of the European Union. Eur J Cancer 2009, 45(15):2640–2648.
5.Wheeler CM: Advances in primary and secondary interventions for cervical cancer: human papillomavirus prophylactic vaccines and testing. Nat Clin Pract Oncol 2007, 4(4):224–235.
6.Naucler P, Ryd W, Tornberg S, Strand A, Wadell G, Elfgren K, Radberg T, Strander B, Johansson B, Forslund O et al: Human papillomavirus and Papanicolaou tests to screen for cervical cancer. N Engl J Med 2007, 357(16):1589–1597.
7.Coquillard G, Palao B, Patterson BK: Quantification of intracellular HPV E6/E7 mRNA expression increases the specificity and positive predictive value of cervical cancer screening compared to HPV DNA. Gynecol Oncol 2011, 120(1):89–93.
8.Nanda K, McCrory DC, Myers ER, Bastian LA, Hasselblad V, Hickey JD, Matchar DB: Accuracy of the Papanicolaou test in screening for and follow-up of cervical cytologic abnormalities: a systematic review. Ann Intern Med 2000, 132(10):810–819.
9.Gustafsson CM, Falkenberg M, Larsson NG: Maintenance and Expression of Mammalian Mitochondrial DNA. Annu Rev Biochem 2016, 85:133–160.
10.Papa S, Skulachev VP: Reactive oxygen species, mitochondria, apoptosis and aging. Mol Cell Biochem 1997, 174(1–2):305–319.
11.Yakes FM, Van Houten B: Mitochondrial DNA damage is more extensive and persists longer than nuclear DNA damage in human cells following oxidative stress. Proc Natl Acad Sci U S A 1997, 94(2):514–519.
12.Picard M, Wallace DC, Burelle Y: The rise of mitochondria in medicine. Mitochondrion 2016, 30:105–116.
13.Lu J, Sharma LK, Bai Y: Implications of mitochondrial DNA mutations and mitochondrial dysfunction in tumorigenesis. Cell research 2009, 19(7):802–815.
14.Kim MM, Clinger JD, Masayesva BG, Ha PK, Zahurak ML, Westra WH, Califano JA: Mitochondrial DNA quantity increases with histopathologic grade in premalignant and malignant head and neck lesions. Clinical cancer research: an official journal of the American Association for Cancer Research 2004, 10(24):8512–8515.
15.Lin CS, Chang SC, Wang LS, Chou TY, Hsu WH, Wu YC, Wei YH: The role of mitochondrial DNA alterations in esophageal squamous cell carcinomas. J Thorac Cardiovasc Surg 2010, 139(1):189–197 e184.
16.Wang Y, Liu VW, Xue WC, Cheung AN, Ngan HY: Association of decreased mitochondrial DNA content with ovarian cancer progression. Br J Cancer 2006, 95(8):1087–1091.
17.Wang Y, Liu VW, Xue WC, Tsang PC, Cheung AN, Ngan HY: The increase of mitochondrial DNA content in endometrial adenocarcinoma cells: a quantitative study using laser-captured microdissected tissues. Gynecol Oncol 2005, 98(1):104–110.
18.Lin CS, Wang LS, Tsai CM, Wei YH: Low copy number and low oxidative damage of mitochondrial DNA are associated with tumor progression in lung cancer tissues after neoadjuvant chemotherapy. Interactive cardiovascular and thoracic surgery 2008, 7(6):954–958.
19.Lee HC, Li SH, Lin JC, Wu CC, Yeh DC, Wei YH: Somatic mutations in the D-loop and decrease in the copy number of mitochondrial DNA in human hepatocellular carcinoma. Mutation research 2004, 547(1–2):71–78.
20.Wen SL, Zhang F, Feng S: Decreased copy number of mitochondrial DNA: A potential diagnostic criterion for gastric cancer. Oncol Lett 2013, 6(4):1098–1102.
21.Cui H, Huang P, Wang Z, Zhang Y, Zhang Z, Xu W, Wang X, Han Y, Guo X: Association of decreased mitochondrial DNA content with the progression of colorectal cancer. BMC Cancer 2013, 13:110.
22.Lee HC, Wei YH: Mitochondrial biogenesis and mitochondrial DNA maintenance of mammalian cells under oxidative stress. Int J Biochem Cell Biol 2005, 37(4):822–834.
23.Shokolenko I, Venediktova N, Bochkareva A, Wilson GL, Alexeyev MF: Oxidative stress induces degradation of mitochondrial DNA. Nucleic acids research 2009, 37(8):2539–2548.
24.Warburg O: On respiratory impairment in cancer cells. Science 1956, 124(3215):269–270.
25.Williams VM, Filippova M, Filippov V, Payne KJ, Duerksen-Hughes P: Human papillomavirus type 16 E6* induces oxidative stress and DNA damage. J Virol 2014, 88(12):6751–6761.
26.Marullo R, Werner E, Zhang H, Chen GZ, Shin DM, Doetsch PW: HPV16 E6 and E7 proteins induce a chronic oxidative stress response via NOX2 that causes genomic instability and increased susceptibility to DNA damage in head and neck cancer cells. Carcinogenesis 2015, 36(11):1397–1406.
27.Jia M, Han J, Hang D, Jiang J, Wang M, Wei B, Dai J, Zhang K, Guo L, Qi J et al: HLA-DP is the cervical cancer susceptibility loci among women infected by high-risk human papillomavirus: potential implication for triage of human papillomavirus-positive women. Tumour Biol 2016, 37(6):8019–8025.
28.Hang D, Yin Y, Han J, Jiang J, Ma H, Xie S, Feng X, Zhang K, Hu Z, Shen H et al: Analysis of human papillomavirus 16 variants and risk for cervical cancer in Chinese population. Virology 2016, 488:156–161.
29.Zhu X, Mao Y, Huang T, Yan C, Yu F, Du J, Dai J, Ma H, Jin G: High mitochondrial DNA copy number was associated with an increased gastric cancer risk in a Chinese population. Mol Carcinog 2017.
30.Warowicka A, Kwasniewska A, Gozdzicka-Jozefiak A: Alterations in mtDNA: a qualitative and quantitative study associated with cervical cancer development. Gynecol Oncol 2013, 129(1):193–198.
31.Kabekkodu SP, Bhat S, Mascarenhas R, Mallya S, Bhat M, Pandey D, Kushtagi P, Thangaraj K, Gopinath PM, Satyamoorthy K: Mitochondrial DNA variation analysis in cervical cancer. Mitochondrion 2014, 16:73–82.
32.Choi YB, Harhaj EW: Functional implications of mitochondrial reactive oxygen species generated by oncogenic viruses. Front Biol (Beijing) 2014, 9(6):423–436.
33.Mushtaq M, Darekar S, Kashuba E: DNA Tumor Viruses and Cell Metabolism. Oxid Med Cell Longev 2016, 2016:6468342.
34.Lai D, Tan CL, Gunaratne J, Quek LS, Nei W, Thierry F, Bellanger S: Localization of HPV–18 E2 at mitochondrial membranes induces ROS release and modulates host cell metabolism. PLoS One 2013, 8(9):e75625.
35.Wei YH, Lee CF, Lee HC, Ma YS, Wang CW, Lu CY, Pang CY: Increases of mitochondrial mass and mitochondrial genome in association with enhanced oxidative stress in human cells harboring 4,977 BP-deleted mitochondrial DNA. Ann N Y Acad Sci 2001, 928:97–112.
36.Zhou X, Wang Y, Si J, Zhou R, Gan L, Di C, Xie Y, Zhang H: Laser controlled singlet oxygen generation in mitochondria to promote mitochondrial DNA replication in vitro. Sci Rep 2015, 5:16925.
37.Saleem A, Adhihetty PJ, Hood DA: Role of p53 in mitochondrial biogenesis and apoptosis in skeletal muscle. Physiol Genomics 2009, 37(1):58–66.
38.Kulawiec M, Ayyasamy V, Singh KK: p53 regulates mtDNA copy number and mitocheckpoint pathway. J Carcinog 2009, 8:8.
39.Safdar A, Khrapko K, Flynn JM, Saleem A, De Lisio M, Johnston AP, Kratysberg Y, Samjoo IA, Kitaoka Y, Ogborn DI et al: Exercise-induced mitochondrial p53 repairs mtDNA mutations in mutator mice. Skelet Muscle 2016, 6:7.
40.Matoba S, Kang JG, Patino WD, Wragg A, Boehm M, Gavrilova O, Hurley PJ, Bunz F, Hwang PM: p53 regulates mitochondrial respiration. Science 2006, 312(5780):1650–1653.
41.Scheffner M, Huibregtse JM, Vierstra RD, Howley PM: The HPV–16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53. Cell 1993, 75(3):495–505.
42.Martinez-Zapien D, Ruiz FX, Poirson J, Mitschler A, Ramirez J, Forster A, Cousido-Siah A, Masson M, Vande Pol S, Podjarny A et al: Structure of the E6/E6AP/p53 complex required for HPV-mediated degradation of p53. Nature 2016, 529(7587):541–545.